Physician Profile

Naomi Rothfield, M.D.

Dr. Naomi Rothfield, professor of medicine in the Division of Rheumatology at the University of Connecticut Health Center. She is an internationally renowned rheumatologist with special expertise in the management of systemic lupus erythematosus, scleroderma and Raynaud’s disease. Dr. Rothfield has published over 100 papers on rheumatologic diseases and her clinical research involves the investigation of new therapies to enhance the care of patients with scleroderma, SLE and Raynaud’s disease.

Appointment

• Professor of Medicine, Division of Rheumatology, UConn Health Center

Specialty

• Internal Medicine

Subspecialty

• Rheumatology
• Scleroderma
• Systemic Lupus Erythematosus
• Osteoarthritis
• Rheumatic Disease
• Gout

Certification
Internal Medicine
Rheumatology

Education
M.D., New York University School of Medicine

State Licensure
Connecticut

Residency
Lenox Hill Hospital

Fellowship
New York University School of Medicine

Awards

• 18th Annual Charles W. Thomas Lecturer from Medical College of Virginia (1988).
• Knowles Lecture from the Northern California Rheumatism Association (1992).
• The Solomon A. Berson Medical Alumni Achievement Award in Clinical Sciences from NYU School of Medicine (1995).
• Master - American College of Rheumatology (1995).

Selected Publications
From a list of 100 publications.

Khanna D., Furst D.E., Clements P.J., Park G.S., Hays R.D., Yoon J, Korn J.H., Merkel P.A., Rothfield, N.F., Wigley F.W., Moreland L.W., Silver R., Steen V.D., Weisman M., Mayes M.D., Collier D., Medsger T.A., Jr. and Seibold J.R., for the Relaxin Study Group and the Scleroderma Clinical Trials Consortium Responsiveness of the SF-36 and the Health Assessment Questionnaire  Disability Index (HAQ-DI) in a Systemic Sclerosis Clinical Trial. J. Rheumatol 33; 832-840, 2005.

Dinesh K., Clements P.J., Furst D.E., Chon Y., Elashoff R., Roth M.D., Sterz M.G., Chung J., FitzGerald J.D., Seibold J.R., Varga J., Theodore A., Wigley F.M., Silver R.M., Steen V.D., Mayes M.D., Connolly M.K., Fessler B.J., Rothfield N.F., MubarakK, Molitor J., Tashkin D.P. Correlation of the Degree of Dyspnea with Health-Related Quality of Life, Functional Abilities, and Diffusing Capacity for Carbon Monoxide in Patients with System Sclerosis and Active Alveolitis. Results from the Scleroderma Lung Study. Arthritis and Rheum 52(2); 592-600, 2005.

Rothfield, N.F. and Lim, A.A.: Systemic lupus erythematosus evolving into rheumatoid arthritis. J. Rheumatol, 33:1 188-190,2006.

Donald P. Tashkin, M.D., Robert Elashoff, Ph.D., Philip J. Clements, M.D., M.P.H., Jonathan Goldin, M.D., Ph.D., Michael D. Roth, M.D., Daniel E. Furst, M.D., Edgar Arriola, Pharm.D., Richard Silver, M.D., Charlie Strange, M.D., Marcy Bolster, M.D., James R. Seibold, M.D., David J. Riley, M.D., Vivien M. Hsu, M.D., John Varga, M.D., Dean E. Schraufnagel, M.D., Arthur Theodore, M.D., Robert Simms, M.D., Robert Wise, M.D., Fredrick Wigley, M.D., Barbara White, M.D., Virginia Steen, M.D., Charles Read, M.D., Maureen Mayes, M.D., Ed Parsley, D.O., Kamal Mubarak, M.D., M. Kari Connolly, M.D., Jeffrey Golden, M.D., Mitchell Olman, M.D., Barri Fessler, M.D., Naomi Rothfield, M.D., Mark Metersky, M.D., for the Scleroderma Lung Study Research Group. Cyclophosphamide versus Placebo in Scleroderma Lung Disease, NEJM, No. 25; 254: 2655-2666, 2006.

M. Luay Alkotob, P. Soltani, M.A., Sheatt, M.C. Katsetos, N. Rothfield, W.D. Hager, R.J. Foley, D.I. Silverman. Reduced exercise capacity and stress induced pulmonary hypertension in patients with scleroderma, Chest, 130: 176-181, 2006.

View more publications, see Pubmed listing.

Research Interests

Clinical Research

• Clinical Trials in scleroderma
• Raynaud’s disease
• Systemic lupus erythematosus.